Key terms
About ENTX
Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. It s pipeline include PTH, GLP-E, and hGh, The company was founded on September 30, 2009 and is headquartered in Jerusalem, Israel.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ENTX news
Apr 15
10:45am ET
Biotech Alert: Searches spiking for these stocks today
Apr 12
11:08am ET
Biotech Alert: Searches spiking for these stocks today
Apr 08
8:54am ET
Entera Bio publishes data on oral PTH peptide tablet for osteoporosis in JBMR
Apr 02
6:30am ET
Analysts Offer Insights on Healthcare Companies: Genelux Corp. (GNLX), Adicet Bio (ACET) and Entera Bio (ENTX)
Mar 20
8:10am ET
Entera Bio announces PK data from oral GLP-2 peptide tablet treatment
Mar 19
4:55am ET
Entera Bio management to meet virtually with Oppenheimer
Mar 18
4:55am ET
Entera Bio management to meet virtually with Oppenheimer
Mar 13
4:08pm ET
Entera Bio management to meet virtually with Oppenheimer
Mar 12
4:55am ET
Entera Bio management to meet with Oppenheimer
Mar 08
4:23pm ET
Entera Bio Ltd Shares Financial Update for Investor Awareness
Mar 08
4:55am ET
Entera Bio management to meet with Oppenheimer
Mar 05
9:45pm ET
Entera Bio management to meet with Oppenheimer
Mar 05
9:44pm ET
Entera Bio management to meet with Oppenheimer
Mar 04
8:40am ET
Entera Bio regains compliance with Nasdaq minimum bid price requirement
Feb 02
4:19pm ET
Entera Bio files to sell 16.5M ordinary shares for holders
Jan 19
11:24am ET
Biotech Alert: Searches spiking for these stocks today
Jan 18
11:32am ET
Biotech Alert: Searches spiking for these stocks today
No recent press releases are available for ENTX
ENTX Financials
Key terms
Ad Feedback
ENTX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ENTX Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range